BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5111969)

  • 1. Blocking considerations in mantle therapy.
    Maruyama Y; Khan FM
    Radiology; 1971 Oct; 101(1):167-73. PubMed ID: 5111969
    [No Abstract]   [Full Text] [Related]  

  • 2. [The appearance of radiation-induced lesions after radiotherapy for Hodgkin's disease of the mediastinum and lungs (author's transl)].
    Zomer-drozda J
    Pol Przegl Radiol Med Nukl; 1976; 40(4):247-50. PubMed ID: 980933
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of radiation injury: predictability and preventability of complications of radiation therapy.
    Stewart JR; Gibbs FA
    Annu Rev Med; 1982; 33():385-95. PubMed ID: 7081967
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of lung irradiation for Hodgkin's disease patient with large mediastinal masses and/or hilar disease.
    Lee CK; Bloomfield CD; Levitt SH
    Cancer Treat Rep; 1982 Apr; 66(4):819-25. PubMed ID: 7074653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical aspects of use of inhibition radiation from an electron accelerator].
    Rabukhina NA; Barkanov AI; Grech IG; Porokhova NP
    Med Radiol (Mosk); 1972 Sep; 17(9):83-94. PubMed ID: 4581845
    [No Abstract]   [Full Text] [Related]  

  • 6. Daily reproducibility of lung blocks in the mantle technique.
    McCord DL; Million RR; Northrop MF; Kavanaugh HV
    Radiology; 1973 Dec; 109(3):735-6. PubMed ID: 4772198
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reticulum cell sarcoma of head and neck treated by radiotherapy].
    Ikeda H; Masaki N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1971 Aug; 31(5):515-27. PubMed ID: 4946426
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of thin lung shields to deliver limited whole-lung irradiation during mantle-field treatment of Hodgkin's disease.
    Palos B; Kaplan HS; Karzmark CJ
    Radiology; 1971 Nov; 101(2):441-2. PubMed ID: 5114786
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary and mediastinal tumor (author's transl)].
    Imajo Y; Ogawa Y; Takashima H; Okuno T; Matsuura S; Ishida T; Kohno M
    Rinsho Hoshasen; 1981 Aug; 26(8):841-6. PubMed ID: 7289146
    [No Abstract]   [Full Text] [Related]  

  • 10. The therapeutic utility of lung irradiation for Hodgkin's disease patients with large mediastinal masses.
    Lee CK; Bloomfield CD; Goldman AI; Nesbit ME; Levitt SH
    Int J Radiat Oncol Biol Phys; 1981 Feb; 7(2):151-4. PubMed ID: 7216852
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lymphosarcomas and reticulosarcomas of the upper aerodigestive tract. Natural history and results of radiotherapy].
    Brugère J; Schleinger M; Gérard-Marchant R; Tubiana M; Pouillart P; Cachin Y
    Bull Cancer; 1974; 61(1):79-92. PubMed ID: 4617613
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radiation myelopathy].
    Fröscher W; Müller J; Vahar-Matiar H
    Nervenarzt; 1975 Jul; 46(7):391-6. PubMed ID: 1207857
    [No Abstract]   [Full Text] [Related]  

  • 13. Stage II Hodgkin's disease. Significance of mediastinal and nonmediastinal presentations.
    Fuller LM; Gamble JF; Ibrahim E; Jing BS; Butler JJ; Shullenberger CC
    Radiology; 1973 Nov; 109(2):429-32. PubMed ID: 4742328
    [No Abstract]   [Full Text] [Related]  

  • 14. [Apropos of radiotherapeutic results in the treatment of lymphoreticulosarcomas with the exception of generalized forms].
    Ennuyer A; Bataini P
    Schweiz Med Wochenschr; 1967 Nov; 97(44):1455-9. PubMed ID: 4874644
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinico-statistical considerations on 104 cases of lymphosarcoma].
    Carnevali G; Salvini E
    Radiol Med; 1967 Dec; 53(12):1278-92. PubMed ID: 5192131
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?
    Ghalibafian M; Beaudre A; Girinsky T
    Radiother Oncol; 2008 Apr; 87(1):82-8. PubMed ID: 18037182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Causes and differences of recurrences in lymphogranulomatosis following primary radiation therapy (author's transl)].
    Sack H; Röttinger EM; Rixen G
    Strahlentherapie; 1978 Oct; 154(10):663-7. PubMed ID: 694956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diseases of the thoracic organs in lymphogranulomatosis].
    Novikova EZ; Savel'eva GS; Khokhlova MP
    Probl Gematol Pereliv Krovi; 1971 Mar; 16(3):27-34. PubMed ID: 5119053
    [No Abstract]   [Full Text] [Related]  

  • 20. [Principles of radiotherapy in tumors of the cervico-mediastinal junction].
    Bertoni F; Bignardi M
    Acta Otorhinolaryngol Ital; 1990; 10 Suppl 30():129-38. PubMed ID: 2103668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.